Literature DB >> 21861994

Methods for isolation of cell-free plasma DNA strongly affect DNA yield.

Michael Fleischhacker1, Bernd Schmidt, Sabine Weickmann, Debora M I Fersching, Gloria S Leszinski, Barbara Siegele, Oliver J Stötzer, Dorothea Nagel, Stefan Holdenrieder.   

Abstract

Extracellular nucleic acids are present in plasma, serum, and other body fluids and their analysis has gained increasing attention during recent years. Because of the small quantity and highly fragmented nature of cell-free DNA in plasma and serum, a fast, efficient, and reliable isolation method is still a problem and so far there is no agreement on a standardized method. We used spin columns from commercial suppliers (QIAamp DNA Blood Midi Kit from Qiagen; NucleoSpin Kit from Macherey-Nagel; MagNA Pure isolation system from Roche Diagnostics) to isolate DNA from 44 plasma samples in parallel at laboratories in Berlin and Munich. DNA in all samples was quantified by real-time PCR on a LightCycler 480 using three different targets (GAPDH, ß-globin, ERV). The quantities of cell-free DNA for the different isolation methods and genes varied between medians of 1.6 ng/mL and 28.1 ng/mL. This considerable variation of absolute DNA values was mainly caused by the use of different isolation methods (p<0.0001). Comparable results were achieved by the use of the genes GAPDH and ERV while higher values were obtained by use of ß-globin. The laboratory site had only minor influence on DNA yield when manual extraction methods were used.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861994     DOI: 10.1016/j.cca.2011.07.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  32 in total

Review 1.  Endorsing good quality assurance practices in molecular pathology: risks and recommendations for diagnostic laboratories and external quality assessment providers.

Authors:  Lien Tembuyser; Elisabeth M C Dequeker
Journal:  Virchows Arch       Date:  2015-08-26       Impact factor: 4.064

Review 2.  Nucleic acids in circulation: are they harmful to the host?

Authors:  Indraneel Mittra; Naveen Kumar Nair; Pradyumna Kumar Mishra
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

Review 3.  Liquid Biopsies in Oncology and the Current Regulatory Landscape.

Authors:  Lindsay N Strotman; Lori M Millner; Roland Valdes; Mark W Linder
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

4.  WT1 Expression in Circulating RNA as a Minimal Residual Disease Marker for AML Patients After Stem-Cell Transplantation.

Authors:  Ling Zhong; Lingling Wei; Jiao Chen; Xiaobing Huang; Yuping Gong; Yanrong Lu
Journal:  Mol Diagn Ther       Date:  2015-08       Impact factor: 4.074

5.  Microfluidic-based solid phase extraction of cell free DNA.

Authors:  Camila D M Campos; Sachindra S T Gamage; Joshua M Jackson; Malgorzata A Witek; Daniel S Park; Michael C Murphy; Andrew K Godwin; Steven A Soper
Journal:  Lab Chip       Date:  2018-11-06       Impact factor: 6.799

6.  Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer.

Authors:  Florent Mouliere; Safia El Messaoudi; Dalong Pang; Anatoly Dritschilo; Alain R Thierry
Journal:  Mol Oncol       Date:  2014-03-24       Impact factor: 6.603

7.  Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.

Authors:  Agnès Marchio; Marie Amougou Atsama; Aubin Béré; Narcisse-Patrice Komas; Dominique Noah Noah; Paul Jean Adrien Atangana; Serge-Magloire Camengo-Police; Richard Njouom; Claudine Bekondi; Pascal Pineau
Journal:  Clin Exp Med       Date:  2018-05-10       Impact factor: 3.984

Review 8.  Circulating cell-free DNA: an up-coming molecular marker in exercise physiology.

Authors:  Sarah Breitbach; Suzan Tug; Perikles Simon
Journal:  Sports Med       Date:  2012-07-01       Impact factor: 11.928

9.  Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients.

Authors:  Elmo W I Neuberger; Alexandra Brahmer; Tobias Ehlert; Katrin Kluge; Keito F A Philippi; Simone C Boedecker; Julia Weinmann-Menke; Perikles Simon
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

10.  Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.

Authors:  Krishna B Sriram; Vandana Relan; Belinda E Clarke; Edwina E Duhig; Morgan N Windsor; Kevin S Matar; Rishendran Naidoo; Linda Passmore; Elizabeth McCaul; Deborah Courtney; Ian A Yang; Rayleen V Bowman; Kwun M Fong
Journal:  BMC Cancer       Date:  2012-09-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.